A BRIEF HISTORY OF MEDICINE MAN TECHNOLOGIES
Medicine Man Technologies is an experienced first-mover and fully integrated operator in the cannabis industry, offering consulting, retail pharma-grade products and turnkey solutions for cannabis cultivators for over a decade. Medicine Man Technologies is leveraging expertise and intellectual property to vertically integrate research, retail, cultivation, formulation and distribution operations with active and past clients in 18 states and seven countries.
Medicine Man Technologies (Ticker: MDCL), offers full-service solutions and a la carte products and services to Clients interested in exploring, entering, or operating in the legal cannabis industry. Our team is composed of cannabis experts with a variety of experience representing cultivation, processing and dispensary operations, finance, compliance, training, design, and other professional skills. Our comprehensive Menu of Services presents your team with the products and solutions to best conduct your cannabis business.
Through our a la carte products and services menu, Medicine Man Technologies provides “off-the-shelf” solutions for clients that may not require a full-service engagement. These items are designed to fulfill specific needs in your planning process or live operation while allowing you to customize the deliverables to meet your requirements. Services may be further customized by our team on a pre-determined hourly rate basis. General consulting is also available to those looking for help with cannabis related topics not listed on our “off-the-shelf” menu. Private consulting fees will be credited back should a client purchase a full-service menu offering. Standard hourly rates apply.
Medicine Man Technologies has experience in consulting individuals and teams with the desire and resources required to enter the cannabis industry. Often, the only thing missing is the experience or “know how” when it comes to designing and operating an efficient cannabis cultivation facility or dispensary. That’s where we come in.
Medicine Man Technologies offers consulting and business planning support for your cannabis business, leveraging the “know how” refined by Medicine Man Denver through 7+ years of operational experience in the Colorado marketplace.
Our risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. Through our licensure services we provide standard operating procedures for all phases of commercial and industrial cannabis cultivation, from clone to counter. In addition, we provide hands-on training and development for your personnel both at Medicine Man Denver and your facility once operational.
Medicine Man Technologies has experience in all areas of cannabis cultivation including: Cloning, Propagation, Vegetative and Flowering husbandry, Drying and Cure techniques utilizing what we call a VCCH model, or Variable Capacity Continuous Harvest model. Our expert team of consultants possess an extensive knowledge of cannabis plant metabolism and physiology, indoor grow protocols and best practices, and the processing of the harvested crop. We can help your legal cannabis cultivation and associated operation overcome challenges to become a market leader.
Our state-of-the art dispensary model ensures patients and consumers have safe and secure access to a variety of medical and/or recreational cannabis products. Through our licensure services we provide standard operating procedures for dispensary facilities, as well as staffing plans, job descriptions and hands-on training for dispensary personnel both at Medicine Man Denver and your facility once operational.
We work closely with industry-leading extraction partners, who provide the necessary licensing service support and formulations to assist clients with their planned deployment of a successful processing facility. This includes; Dixie Elixirs, Medically Correct, CanCore Concepts, and Tree Frog.
Operating in this emerging industry requires experienced partners who can help you avoid costly mistakes. Medicine Man Technologies’ team of professional consultants can help you navigate the process of becoming a successful cannabis operation. If you’re interested in learning more, we would love to hear from you.
Andy Williams – Chairman of the Board
Andy Williams is among America’s most pioneering thought leaders and entrepreneurs in the legal cannabis space.
As co-founder and CEO of industry-leading consultancy Medicine Man Technologies, Williams has expanded his influence exponentially – helping entrepreneurs in other states via his extensive cultivation expertise and unparalleled business acumen. As a founding partner in phytopharmaceutical company MedPharm, Williams is investing heavily in the future of pharmaceutical-grade cannabis research.
With years of experience in the world’s first regulated market, Williams is a leading expert on the cannabis industry. He has been featured in The New York Times, Rolling Stone, CNN, The Wall Street Journal, BBC and the MSNBC docu-series “Pot Barons,” which focused on Williams as one of the show’s central characters.
Williams continues to elevate his politically active leadership in the ever-expanding marijuana industry, working daily to protect and grow the cannabis industry as a board member with the Cannabis Trade Federation, which works federally on tax reform and other industry-specific issues, and Colorado Leads, a pro-growth organization focusing its efforts locally.
He also serves as a board member for Flatirons Venture Partners, LLC, The American Trade Association for Cannabis and Hemp and as a voting member on ASTM Committee D37 on Cannabis, which is currently developing important standards for cannabis, its products and processes for the esteemed worldwide standards organization.
Williams is proud to serve as co-founder and director of the Medicine Man Family Foundation, a community-focused nonprofit investing in impact-driven projects rooted in the communities in which the Medicine Man brand operates.
Joe Puglise – COO
In his role as COO, Mr. Puglise will be responsible for management of day-to-day sales and general operations activities. Mr. Puglise brings considerable experience in operational management, most recently at the Beekman Group where he serves as an Industry Partner and Board Member for a portfolio company holding, helping them to grow through both organic and acquisition means. Prior to that, he was President of New York properties for iHeartMedia, where he oversaw approximately 300 employees and almost $200m in annual revenue and $100m in annual EBITDA. Additionally, he has held board positions with organizations including the Ad Council of New York, the Annenberg Center at the University of Pennsylvania, Alliance for Lupus Research (ALR) 2014 Walk Co-Chair and Big Brother and Big Sisters of Central Arizona. Mr. Puglise is a 1992 magna cum laude graduate of the Wharton School of Business.
Josh Haupt – Chief Cultivation Officer
Joshua Haupt, recognized as “the Steve Jobs of Marijuana” is being recognized for his innovative growing technique and entrepreneurship in the Cannabis Industry, in addition to his inspiring story that led him there.
After being diagnosed with epilepsy as a young teenager, Haupt turned to cannabis to replace the harmful steroids and medications prescribed to him by his doctors. From there, his budding interest in the cannabis plant bloomed into a fruitful garden. And with countless hours of research and growing trials, Josh perfected his growing methodology. Now Haupt is the Chief Cultivation Officer of Medicine Man Technologies, author of Three A Light, and the owner of Superfarm, Success Nutrients, and Tall T Productions.
His method, morals and operations are radically revolutionizing the cannabis industry. Haupt was born in Hawaii and currently resides in Denver, Colorado.
Todd Williams – Chief Strategy Officer
Todd Williams joins Medicine Man Technologies as Chief Strategy Officer, with more than 24 years of consulting, strategy, asset valuation and M&A experience. In his most recent role in Corporate Development at Albertsons Companies, he managed the acquisition of over 1,600 operating grocery stores with more than $40 billion in sales and $10 billion in transaction value and was also responsible for divesting 168 stores with over $3 billion in sales. Previously, Mr. Williams has held asset valuation and management positions in real estate and commodity trading, as well as management consulting positions with Arthur Andersen LLP and Electronic Data Systems. He received a B.A. from DePauw University and graduated with academic honors.
Lee A. Dayton, JR – Chief Administration Officer
Mr. Dayton brings more than 25 years of experience in investment banking, corporate development, and strategic partnerships. More recently, he served as Vice President of Corporate Development and Strategy at Albertsons Companies. There he conducted research and due diligence on customer-focused technologies to grow Albertsons non-brick and mortar businesses. Prior to that, Mr. Dayton worked in investment banking at UBS, Morgan Stanley and Citigroup, with a focus on retail, healthcare and industrials. He is an MBA graduate of the Kellogg School of Management and received his B.S. in electrical engineering from McCormick School of Engineering, both at Northwestern University.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for Medicine Man Technologies, Inc. current news coverage by a non affiliated third party. FNMG HOLDS NO SHARES OF Medicine Man Technologies, Inc.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.